AMS Israel develops innovative products based on a proprietary platform of alga-mimetic tissue adhesives, for a variety of applications and clinical needs in surgical adhesion, leakage control, adhesion-prevention and drug delivery.

The Sealantis alga-mimetic adhesives present a true breakthrough in the realm of biosurgicals, providing a sophisticated tissue adhesive technology with superior efficacy, safety and ease of use. Mimicking the underwater adherence mechanism of algae, the Sealantis adhesive technology platform opens a gateway to a variety of potential applications in surgery, injuries, and drug delivery.

The platform comprises a protein-free adhesive based on Alginate, a natural polymer produced by algae.